FluidForm is a startup based in the United States.
FluidForm develops a proprietary 3D bioprinting platform called FRESH to create implantable, vascularized tissues aimed at treating diseases like type 1 diabetes with minimally invasive, implantable solutions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.